Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors

Nutrients

Volumn 11, Issue 1, 2019, Pages

  de la Cuesta Zuluaga, Jacobo ^a,g   Mueller, Noel T ^b,c   Álvarez Quintero, Rafael ^d   Velásquez Mejía, Eliana P ^a   Sierra, Jelver A ^a   Corrales Agudelo, Vanessa ^a   Carmona, Jenny A ^e,h   Abad, José M ^f   Escobar, Juan S ^a  

^a Grupo Empresarial Nutresa   (Colombia)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^e Centro Lab IPS   (Colombia)

^f EPS SURA   (Colombia)

^g MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

^h SURA Colombia   (Colombia)

Author keywords

Adiposity; Butyrate; Gut microbiota; Gut permeability; Hypertension; Metabolic dysregulation; SCFA

Indexed keywords

ACETIC ACID; ADIPONECTIN; BUTYRIC ACID DERIVATIVE; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOBUTYRIC ACID; LEPTIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROPIONIC ACID; RNA 16S; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VOLATILE FATTY ACID;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOMETABOLIC RISK; CHEMILUMINESCENCE IMMUNOASSAY; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; DYSBIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GENE SEQUENCE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERTENSION; IMMUNOTURBIDIMETRY; INSULIN RESISTANCE; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; MICROBIAL DIVERSITY; NUTRITIONAL ASSESSMENT; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SENSITIVITY ANALYSIS; SKINFOLD THICKNESS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADOLESCENT; CARDIOVASCULAR DISEASE; CHEMISTRY; FECES; METABOLISM; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERTENSION; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 85059240887     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu11010051     Document Type: Article

References (56)

1. Flint, H.J.; Scott, K.P.; Duncan, S.H.; Louis, P.; Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012, 3, 289–306. [CrossRef] [PubMed]
2. Stumpff, F. A look at the smelly side of physiology: Transport of short chain fatty acids. Pflugers Arch. Eur. J. Physiol. 2018, 470, 571–598. [CrossRef] [PubMed]
3. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.J.; Brummer, R.J. Review article: The role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104–119. [CrossRef] [PubMed]
4. Den Besten, G.; Lange, K.; Havinga, R.; van Dijk, T.H.; Gerding, A.; van Eunen, K.; Muller, M.; Groen, A.K.; Hooiveld, G.J.; Bakker, B.M.; et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. AJP Gastrointest. Liver Physiol. 2013, 305, G900–G910. [CrossRef] [PubMed]
5. Kelly, C.J.; Zheng, L.; Campbell, E.L.; Saeedi, B.; Scholz, C.C.; Bayless, A.J.; Wilson, K.E.; Glover, L.E.; Kominsky, D.J.; Magnuson, A.; et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 2015, 17, 662–671. [CrossRef] [PubMed]
6. Peng, L.; Li, Z.-R.; Green, R.S.; Holzman, I.R.; Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 2009, 139, 1619–1625. [CrossRef] [PubMed]
7. Jung, T.H.; Park, J.H.; Jeon, W.M.; Han, K.S. Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway. Nutr. Res. Pract. 2015, 9, 343–349. [CrossRef]
8. Cani, P.D.; Bibiloni, R.; Knauf, C.; Neyrinck, A.M.; Delzenne, N.M. Changes in gut microbiota control metabolic diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470–1481. [CrossRef]
9. Byrne, C.S.; Chambers, E.S.; Morrison, D.J.; Frost, G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. 2015, 39, 1331–1338. [CrossRef]
10. Vieira, A.T.; MacIa, L.; Galvão, I.; Martins, F.S.; Canesso, M.C.C.; Amaral, F.A.; Garcia, C.C.; Maslowski, K.M.; De Leon, E.; Shim, D.; et al. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 2015, 67, 1646–1656. [CrossRef]
11. Smith, P.M.; Howitt, M.R.; Panikov, N.; Michaud, M.; Gallini, C.A.; Bohlooly, Y.M.; Glickman, J.N.; Garrett, W.S.; Bohlooly, Y.M.; Glickman, J.N.; et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341, 569–573. [CrossRef] [PubMed]
12. McNeil, N.I. The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr. 1984, 39, 338–342. [CrossRef] [PubMed]
13. Rahat-Rozenbloom, S.; Fernandes, J.; Gloor, G.B.; Wolever, T.M.S. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int. J. Obes. 2014, 38, 1525–1531. [CrossRef] [PubMed]
14. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027–1031. [CrossRef] [PubMed]
15. Schwiertz, A.; Taras, D.; Schafer, K.; Beijer, S.; Bos, N.A.; Donus, C.; Hardt, P.D.; Schäfer, K.; Beijer, S.; Bos, N.A.; et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18, 190–195. [CrossRef] [PubMed]
16. Jumpertz, R.; Le, D.S.; Turnbaugh, P.J.; Trinidad, C.; Bogardus, C.; Gordon, J.I.; Krakoff, J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 2011, 94, 58–65. [CrossRef] [PubMed]
17. Turnbaugh, P.J.; Hamady, M.; Yatsunenko, T.; Cantarel, B.L.; Duncan, A.; Ley, R.E.; Sogin, M.L.; Jones, W.J.; Roe, B.A.; Affourtit, J.P.; et al. A core gut microbiome in obese and lean twins. Nature 2009, 457, 480–487. [CrossRef]
18. Zweigner, J.; Schumann, R.R.; Weber, J.R. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect. 2006, 8, 946–952. [CrossRef]
19. Siri, W. Body Composition from Fluid Spaces and Density: Analysis of Methods; National Academy of Sciences: Washington, DC, USA, 1961; Volume 1, ISBN 9788578110796.
20. IPAQ Research Committee Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Available online: http://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_ Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents (accessed on 1 June 2017).
21. De la Cuesta-Zuluaga, J.; Mueller, N.T.; Corrales-Agudelo, V.; Velásquez-Mejía, E.P.; Carmona, J.A.; Abad, J.M.; Escobar, J.S. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid–producing microbiota in the gut. Diabetes Care 2017, 40, 54–62. [CrossRef]
22. Schloss, P.D.; Westcott, S.L.; Ryabin, T.; Hall, J.R.; Hartmann, M.; Hollister, E.B.; Ryan, A.; Oakley, B.B.; Parks, D.H.; Courtney, J.; et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 2009, 75, 7537–7541. [CrossRef]
23. DeSantis, T.Z.; Hugenholtz, P.; Larsen, N.; Rojas, M.; Brodie, E.L.; Keller, K.; Huber, T.; Dalevi, D.; Hu, P.; Andersen, G.L. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006, 72, 5069–5072. [CrossRef] [PubMed]
24. Kindt, R. Coe, R. Tree Diversity Analysis. A Manual and Software for Common Statistical Methods for Ecological and Biodiversity Studies; World Agroforestry Centre (ICRAF): Nairobi, Kenya, 2005; ISBN 92-9059-179-X.
25. Chen, J.; Bittinger, K.; Charlson, E.S.; Hoffmann, C.; Lewis, J.; Wu, G.D.; Collman, R.G.; Bushman, F.D.; Li, H. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics 2012, 28, 2106–2113. [CrossRef] [PubMed]
26. Storey, J.D.; Bass, A.J.; Dabney, A.; Robinson, D. qvalue: Q-Value Estimation for False Discovery Rate Control. Available online: http://github.com/jdstorey/qvalue (accessed on 17 April 2018).
27. Claesson, M.J.; Cusack, S.; O’Sullivan, O.; Greene-Diniz, R.; de Weerd, H.; Flannery, E.; Marchesi, J.R.; Falush, D.; Dinan, T.; Fitzgerald, G.; et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA 2011, 108, 4586–4591. [CrossRef] [PubMed]
28. De la Cuesta-Zuluaga, J.; Corrales-Agudelo, V.; Velásquez-Mejía, E.P.; Carmona, J.A.; Abad, J.M.; Escobar, J.S. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization. Sci. Rep. 2018, 8, 11356. [CrossRef] [PubMed]
29. Clarke, S.F.; Murphy, E.F.; O’Sullivan, O.; Lucey, A.J.; Humphreys, M.; Hogan, A.; Hayes, P.; O’Reilly, M.; Jeffery, I.B.; Wood-Martin, R.; et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 2014, 63, 1913–1920. [CrossRef] [PubMed]
30. Peres-Neto, P.R.; Jackson, D.A. How well do multivariate data sets match? The advantages of a procrustean superimposition approach over the Mantel test. Oecologia 2001, 129, 169–178. [CrossRef] [PubMed]
31. Forslund, K.; Hildebrand, F.; Nielsen, T.; Falony, G.; Le Chatelier, E.; Sunagawa, S.; Prifti, E.; Vieira-Silva, S.; Gudmundsdottir, V.; Krogh Pedersen, H.; et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015, 528, 262–266. [CrossRef]
32. Fernandes, J.; Su, W.; Rahat-Rozenbloom, S.; Wolever, T.M.; Comelli, E.M. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 2014, 4, e121. [CrossRef]
33. Teixeira, T.F.S.; Grześkowiak, Ł.; Franceschini, S.C.C.; Bressan, J.; Ferreira, C.L.L.F.; Peluzio, M.C.G. Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br. J. Nutr. 2013, 109, 914–919. [CrossRef]
34. Ppatil, D.; Pdhotre, D.; Gchavan, S.; Sultan, A.; Jain, D.S.; Lanjekar, V.B.; Gangawani, J.; Sshah, P.; Stodkar, J.; Shah, S.; et al. Molecular analysis of gut microbiota in obesity among Indian individuals. J. Biosci. 2012, 37, 647–657. [CrossRef]
35. Vogt, J.A.; Wolever, T.M. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J. Nutr. 2003, 133, 3145–3148. [CrossRef] [PubMed]
36. Binder, H.J. Role of colonic short-chain fatty acid transport in diarrhea. Annu. Rev. Physiol. 2010, 72, 297–313. [CrossRef] [PubMed]
37. Boets, E.; Deroover, L.; Houben, E.; Vermeulen, K.; Gomand, S.V.; Delcour, J.A.; Verbeke, K. Quantification of in vivo colonic short chain fatty acid production from inulin. Nutrients 2015, 7, 8916–8929. [CrossRef]
38. Layden, B.T.; Yalamanchi, S.K.; Wolever, T.M.; Dunaif, A.; Lowe, W.L., Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab. Syndr. Obes. 2012, 5, 49–55. [CrossRef] [PubMed]
39. Zhao, L.; Zhang, F.; Ding, X.; Wu, G.; Lam, Y.Y.; Shi, Y.; Shen, Q.; Dong, W.; Liu, R.; Ling, Y.; et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 2018, 359, 1151–1156. [CrossRef]
40. Gao, Z.; Yin, J.; Zhang, J.; Ward, R.E.; Martin, R.J.; Lefevre, M.; Cefalu, W.T.; Ye, J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58, 1509–1517. [CrossRef] [PubMed]
41. Den Besten, G.; Bleeker, A.; Gerding, A.; van Eunen, K.; Havinga, R.; van Dijk, T.H.; Oosterveer, M.H.; Jonker, J.W.; Groen, A.K.; Reijngoud, D.-J.; et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 2015, 64, 2398–2408. [CrossRef]
42. Matheus, V.A.; Monteiro, L.C.S.; Oliveira, R.B.; Maschio, D.A.; Collares-Buzato, C.B. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Exp. Biol. Med. 2017, 242, 1214–1226. [CrossRef]
43. Guo, S.; Al-Sadi, R.; Said, H.M.; Ma, T.Y. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 2013, 182, 375–387. [CrossRef]
44. Cani, P.D.; Amar, J.; Iglesias, M.A.; Poggi, M.; Knauf, C.; Bastelica, D.; Neyrinck, A.M.; Fava, F.; Tuohy, K.M.; Chabo, C.; et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761–1772. [CrossRef]
45. Albenberg, L.; Esipova, T.V.; Judge, C.P.; Bittinger, K.; Chen, J.; Laughlin, A.; Grunberg, S.; Baldassano, R.N.; Lewis, J.D.; Li, H.; et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014, 147, 1055–1063. [CrossRef] [PubMed]
46. Shin, N.R.; Whon, T.W.; Bae, J.W. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015, 33, 496–503. [CrossRef] [PubMed]
47. Litvak, Y.; Byndloss, M.X.; Tsolis, R.M.; Bäumler, A.J. Dysbiotic Proteobacteria expansion: A microbial signature of epithelial dysfunction. Curr. Opin. Microbiol. 2017, 39, 1–6. [CrossRef] [PubMed]
48. The Human Microbiome Project Consortium; Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; Chinwalla, A.T.; Creasy, H.H.; Earl, A.M.; FitzGerald, M.G.; et al. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214. [CrossRef]
49. Napolitano, A.; Miller, S.; Nicholls, A.W.; Baker, D.; Van Horn, S.; Thomas, E.; Rajpal, D.; Spivak, A.; Brown, J.R.; Nunez, D.J. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE 2014, 9, e100778. [CrossRef]
50. Everard, A.; Belzer, C.; Geurts, L.; Ouwerkerk, J.P.; Druart, C.; Bindels, L.B.; Guiot, Y.; Derrien, M.; Muccioli, G.G.; Delzenne, N.M.; et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 2013, 110, 9066–9071. [CrossRef] [PubMed]
51. Million, M.; Angelakis, E.; Maraninchi, M.; Henry, M.; Giorgi, R.; Valero, R.; Vialettes, B.; Raoult, D. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int. J. Obes. 2013, 37, 1460–1466. [CrossRef] [PubMed]
52. Goodrich, J.K.; Waters, J.L.; Poole, A.C.; Sutter, J.L.; Koren, O.; Blekhman, R.; Beaumont, M.; Van Treuren, W.; Knight, R.; Bell, J.T.; et al. Human genetics shape the gut microbiome. Cell 2014, 159, 789–799. [CrossRef]
53. Konikoff, T.; Gophna, U. Oscillospira: A central, enigmatic component of the human gut microbiota. Trends Microbiol. 2016, 24, 523–524. [CrossRef]
54. Louis, S.; Tappu, R.M.; Damms-Machado, A.; Huson, D.H.; Bischoff, S.C. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS ONE 2016, 11, e0149564. [CrossRef]
55. Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Cheng, J.; Duncan, A.E.; Kau, L.; Griffi, N.W.; Lombard, V.; Henrissat, B.; Bain, J.R.; et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341, 1241214. [CrossRef] [PubMed]
56. Bäumler, A.J.; Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 2016, 535, 85–93. [CrossRef] [PubMed]